z-logo
Premium
Isolation and characterization of the translation product of a β‐globin gene nonsense mutation (β121 GAA→TAA)
Author(s) -
Adams Junius G.,
Steinberg Martin H.,
Kazazian Haig H.
Publication year - 1990
Publication title -
british journal of haematology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.907
H-Index - 186
eISSN - 1365-2141
pISSN - 0007-1048
DOI - 10.1111/j.1365-2141.1990.tb07799.x
Subject(s) - nonsense mutation , microbiology and biotechnology , globin , biology , heterozygote advantage , compound heterozygosity , exon , gene , beta (programming language) , gene product , isoelectric focusing , allele , mutation , chemistry , biochemistry , missense mutation , gene expression , enzyme , computer science , programming language
S ummary . The β°‐thalassaemia gene of an individual who was a mixed heterozygote for this allele (GAA to TAA in codon 12) and β + ‐thalassaemia (IVS‐1 position 110 G to A) was examined to determine if the β°‐thalassaemia allele directed the synthesis of any detectable protein product. This β°‐thalassaemia allele was of particular interest, because it is the only example of a premature chain termination codon in the third exon of the β‐globin gene that produces thalassaemia. A very small amount of an abnormal protein was found in the red blood cells of the proband and was purified by preparative column chromatography. This abnormal protein was digested with trypsin, the peptides were separated by reverse phase high performance liquid chromatography (HPLC), and the amino acid content of each peptide was determined. All of the soluble β‐globin peptides were found except for T‐13. T‐14 and T‐15 (residues 121‐146), indicating the presence of a truncated protein that corresponded to the translation product of the β121 Glu→Term mRNA. This truncated globin was estimated to comprise between 0.05% and 0.1% of the total non‐α‐globin protein. These results may explain the phenotype of inclusion body β‐thalassaemia in heterozygotes, which is atypical of heterozygous β°‐thalassaemia.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom